Muscle weakness and frailty adversely affect late-stage liver disease, study finds
AMRA Medical Research Results Support Strengthening Sarcopenia Guidelines AMRA Medical’s research publication in JHEP Reports details the link between MRI-based adverse muscle composition and NAFLD metabolic comordidity & poor function. Linköping, Sweden,…
Autumn 2020 offers a crop of EASL hepatology fellowships
From ground-breaking discoveries to the Nobel Prize 2020, hepatology is cutting edge. This autumn, EASL has a crop of exciting fellowships on offer, to foster the next generation of bright minds. Are…
Hepatitis C scientists in the limelight: Nobel Prize 2020
5 October 2020 The Nobel Prize in Physiology or Medicine 2020 has been awarded jointly to Harvey J. Alter, Michael Houghton, and Charles M. Rice for the discovery of hepatitis C virus…
Patients with cirrhosis at increased risk of death from COVID-19, study finds
An international study led by researchers at Oxford University Hospitals NHS Foundation Trust has shown that patients with cirrhosis are at increased risk of dying as a result of COVID-19. Oxford, October…
Calling transplant centres to share how they are affected by COVID-19
19 September 2020 EASL is part of a joint initiative on the impact of COVID-19 on liver transplantation, aiming to explore how patients, healthcare professionals, and liver transplant centres across the world…
Global Week for Action on NCDs: We need more accountability
This week, 7-13 September, marks the 2020 Global Week for Action on NCDs (non-communicable diseases). The campaign draws on energy, inspiration, determination, optimism, and outrage to focus efforts on ensuring NCD prevention…
A pioneer in transplantation: a tribute to Prof. Chris Gips (17 February 1932 – 29 July 2020)
It is with great sadness that EASL announces the passing of Prof. Christiaan Hendrik (Chris) Gips, a pioneer in liver transplantation, patient empowerment, and education in the field of hepatology. His work…